Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LABORATORIO REIG JOFRE S.A. (GB:0RB1)
LSE:0RB1
Holding GB:0RB1?
Track your performance easily
0RB1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.23 - €3.18
Previous Close€2.59
Volume32.00
Average Volume (3M)229.00
Market Cap
€208.10M
Enterprise Value€264.03M
Total Cash (Recent Filing)€13.17M
Total Debt (Recent Filing)€69.10M
Price to Earnings (P/E)21.2
Beta0.33
Next Earnings
Feb 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 17, 2024Dividend Yield1.27%
Share Statistics
EPS (TTM)0.12
Shares OutstandingN/A
10 Day Avg. Volume220
30 Day Avg. Volume229
Standard Deviation0.16
R-Squared0.06
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.55
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LABORATORIO REIG JOFRE News
PremiumCompany Announcements
Reig Jofre Reports Strong Q3 Growth Amid Global Expansion
PremiumCompany Announcements
Reig Jofre Reports Q3 Liquidity Contract Movements
PremiumCompany Announcements
Reig Jofre Expands European Footprint with Czech Subsidiary
PremiumCompany Announcements
Reig Jofre Posts Strong Growth in First Semester 2024
PremiumCompany Announcements
Reig Jofre Updates on Quarterly Liquidity Movements
PremiumCompany Announcements
Reig Jofre Extends Liquidity Contract Indefinitely
PremiumCompany Announcements
Reig Jofre’s New Shares Commence Trading
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
0RB1 FAQ
What was LABORATORIO REIG JOFRE S.A.’s price range in the past 12 months?
LABORATORIO REIG JOFRE S.A. lowest share price was €2.23 and its highest was €3.18 in the past 12 months.
What is LABORATORIO REIG JOFRE S.A.’s market cap?
Currently, no data Available
When is LABORATORIO REIG JOFRE S.A.’s upcoming earnings report date?
LABORATORIO REIG JOFRE S.A.’s upcoming earnings report date is Feb 26, 2025 which is in 66 days.
How were LABORATORIO REIG JOFRE S.A.’s earnings last quarter?
LABORATORIO REIG JOFRE S.A. released its earnings results on Oct 31, 2024. The company reported €0.031 earnings per share for the quarter, beating the consensus estimate of N/A by €0.031.
Is LABORATORIO REIG JOFRE S.A. overvalued?
According to Wall Street analysts LABORATORIO REIG JOFRE S.A.’s price is currently Overvalued.
Does LABORATORIO REIG JOFRE S.A. pay dividends?
LABORATORIO REIG JOFRE S.A. pays a Annually dividend of €0.032 which represents an annual dividend yield of 1.27%. See more information on LABORATORIO REIG JOFRE S.A. dividends here
What is LABORATORIO REIG JOFRE S.A.’s EPS estimate?
LABORATORIO REIG JOFRE S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LABORATORIO REIG JOFRE S.A. have?
LABORATORIO REIG JOFRE S.A. has 80,895,750 shares outstanding.
What happened to LABORATORIO REIG JOFRE S.A.’s price movement after its last earnings report?
LABORATORIO REIG JOFRE S.A. reported an EPS of €0.031 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LABORATORIO REIG JOFRE S.A.?
Currently, no hedge funds are holding shares in GB:0RB1
---
LABORATORIO REIG JOFRE Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.49%
12-Months-Change
Fundamentals
Return on Equity
4.61%
Trailing 12-Months
Asset Growth
2.36%
Trailing 12-Months
Company Description
LABORATORIO REIG JOFRE S.A.
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
---
Technical Analysis
---